Copy to clipboard 
Guardian Medical USA announced that it successfully raised more than $2 million in recent private financing.
The company has made steady progress in gaining key customers in the spine, foot/ankle and trauma orthopedic market segments, said Tracy Momany, CEO, Guardian Medical USA. The funding allows Guardian to accelerate product development and facilities growth to meet upcoming demand and significant interest in using rigid tubes to sterile package orthopedic implants and devices of all types and sizes.
Since its founding, Guardian Medical USA has invested in creating a sterile tube packaging system, CapSure, with a pre-validated seal having unequaled functional characteristics and abilities. The company meets the requisite ISO 13485 and packaging standards for sterile barrier medical device packaging.
Guardian Medical USA has invested in creating a sterile tube packaging system, CapSure, with a pre-validated seal having unequaled functional characteristics and abilities.
The capital raise was led by Queen City Angels (Cincinnati, Ohio). Key investors were Jump Start, Inc., Rocket Innovations Holdings and Lateral Capital VI, LP, in addition to numerous individual investors associated with Queen City Angels.
“In combination with Jump Start, Rocket Innovations, and Lateral Capital, we are proud to have to invested in Guardian Medical USA, a ‘hometown’ company that has a significant market opportunity in the medical device market,” said Ross Bushman, Queen City Angels Investor Member and Guardian Medical Board Member.
Source: Guardian Medical
